Reata Pharmaceuticals, Inc.
Reata Pharmaceuticals, Inc. (RETA) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · RETA · as of Sep 30, 2023
Ownership Breakdown
3
Institutional Holders
▼ 237 vs Q2
$4.59M
Total Inst. Value
▼ $3.21B vs Q2
38.10M
Shares Outstanding
freeFloat 78.19%
111,011
13F Shares Held
▼ 31.41M vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
RETA largest shareholders · institutional ownership
Q3 2023 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO pharmaceutical preparations | 93.7K | 22.58% | 22.58% | $1.61B | Nov 14, 2023 | ▲ 90.3K |
DEKABANK DEUTSCHE GIROZENTRALE pharmaceutical preparations | 17.0K | 4.10% | 4.10% | $2.93B | Nov 13, 2023 | — held |
IFP ADVISORS, INC pharmaceutical preparations | 300 | 0.07% | 0.07% | $51.71M | Oct 12, 2023 | — held |
JPMORGAN CHASE & CO pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Nov 14, 2023 | EXIT |
BANK OF AMERICA CORP /DE/ pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Nov 14, 2023 | EXIT |
WELLS FARGO & COMPANY/MN pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Nov 13, 2023 | EXIT |
FRANKLIN RESOURCES INC pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Nov 13, 2023 | EXIT |
PRICE T ROWE ASSOCIATES INC /MD/ pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Nov 14, 2023 | EXIT |
STATE STREET CORP pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Nov 14, 2023 | EXIT |
NORTHERN TRUST CORP pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Nov 13, 2023 | EXIT |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2023 vs prior quarter
Q3 2023
1
Increased
+90.3K shares0
New Positions
first time holders0
Decreased
−0 shares47
Sold Out
fully exitedNet shares change (top 50)
+90.3K
+90.3K / −0
Net new holders
-46
0 new / 47 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
RETA insider trading · insider activity
Source: SEC Form 4
19
Buy transactions
136
Sell transactions
0.14
Buy/Sell ratio
$6M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Desai Antal Rohit
| Sep 26, 2023 | D-Return | 993,929 | — | — | 0 | Form 4 ↗ |
Desai Antal Rohit
| Sep 26, 2023 | D-Return | 134 | $172.50 | $23.1K | 0 | Form 4 ↗ |
McGaughy R Kent Jr
| Sep 26, 2023 | D-Return | 2,773 | $22.57 | $62.6K | 0 | Form 4 ↗ |
McGaughy R Kent Jr
| Sep 26, 2023 | D-Return | 690 | $146.01 | $100.7K | 0 | Form 4 ↗ |
McGaughy R Kent Jr
| Sep 26, 2023 | D-Return | 3,185 | $25.52 | $81.3K | 0 | Form 4 ↗ |
McGaughy R Kent Jr
| Sep 26, 2023 | D-Return | 6,000 | $22.57 | $135.4K | 0 | Form 4 ↗ |
McGaughy R Kent Jr
| Sep 26, 2023 | D-Return | 280 | $172.50 | $48.3K | 0 | Form 4 ↗ |
McGaughy R Kent Jr
| Sep 26, 2023 | D-Return | 278,309 | — | — | 0 | Form 4 ↗ |
McGaughy R Kent Jr
| Sep 26, 2023 | D-Return | 699 | $130.92 | $91.5K | 0 | Form 4 ↗ |
McGaughy R Kent Jr
| Sep 26, 2023 | D-Return | 4,787 | $34.76 | $166.4K | 0 | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Reata Pharmaceuticals, Inc. (RETA) is primarily owned by institutional investors, who hold approximately 0.3% of total shares outstanding. Company insiders own approximately 21.81%, while retail and public investors account for the remaining 77.90%.
The largest institutional shareholder of Reata Pharmaceuticals, Inc. is PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO, holding approximately 93,711 shares — equal to 22.58% of outstanding shares — as of September 30, 2023.
A total of 3 institutional investors currently hold RETA stock, with a combined institutional value of approximately $4,593,708 as of the most recent 13F filing period.
Frequently asked questions
RETA ownershipReata Pharmaceuticals, Inc. (RETA) is primarily owned by institutional investors, who hold approximately 0.3% of shares. The largest shareholder is PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO with a 22.58% stake. Company insiders hold 21.81%. Data sourced from SEC Form 13F as of September 30, 2023.